Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OBV/PTV/r ± DSV plus ribavirin in adults with chronic hepatitis C after prior treatment of early hepatocellular carcinoma
2015-001049-10Phase 3Terminated
- Sponsor
- AbbVie Inc.
- Start
- Jul 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ombitasvir, paritaprevir, ritonavir, dasabuvir, ribavirin in hepatitis C virus infection, sponsored by AbbVie Inc.. Started Jul 2015; status: terminated.
02
Drugs
ombitasvirparitaprevirritonavirdasabuvirribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2015-001049-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001049-10.